3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Breast
1
Conditions
Breast Neoplasms
165
Polycystic Ovary Syndrome
23
Neoplasm Metastasis
9
Osteoporosis
7
Neoplasms
6
Infertility
6
Endometrial Neoplasms
5
Carcinoma, Intraductal, Noninfiltrating
5
Ovarian Neoplasms
4
Breast Carcinoma In Situ
4
Arthralgia
4
Hereditary Sensory and Autonomic Neuropathies
3
Carcinoma, Ductal, Breast
3
Breast Neoplasms, Male
3
Breast Cancer Metastatic
3
Advanced Breast Cancer
3
Triple Negative Breast Neoplasms
2
Recurrence
2
Pain
2
Leiomyoma
2
Fallopian Tube Neoplasms
2
Estrogen Receptor-positive Breast Cancer
2
Carcinoma, Lobular
2
Bone Diseases, Metabolic
2
Uterine Neoplasms
1
Patient Acceptance of Health Care
1
Ovarian Cysts
1
Osteitis Deformans
1
Obesity
1
Neoplastic Cells, Circulating
1
Interventions
Blood Specimen Collection
3
veliparib
2
Surveys and Questionnaires
2
Counseling
2
Carboplatin
2
Zoledronic Acid
1
Videotape Recording
1
Telemedicine
1
Taxes
1
Tamoxifen
1
Standard of Care
1
Specimen Handling
1
Psychiatric Rehabilitation
1
Practice Guidelines as Topic
1
Palliative Care
1
Paclitaxel
1
Letrozole
1
Genotype
1
Genetic Counseling
1
Exercise Test
1
Echocardiography
1
Early Intervention, Educational
1
Docetaxel
1
Diet, Mediterranean
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Hereditary Breast and Ovarian Cancer Syndrome
×
Letrozole
×
Clear all
NCT00673335
2024-07-01
LIBER
UNICANCER
Phase 3
Completed
170 enrolled